{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:44:39Z","timestamp":1792626279389,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Postural orthostatic tachycardia syndrome (POTS) is associated with multiple autonomic symptoms, including gastrointestinal (GI) complaints, and has been linked to insulin resistance. We aimed to explore HbA1c, circulating metabolic hormones (insulin, C-peptide, GIP, GLP-1, glucagon, leptin, and peptide YY) and cortisol, and their associations with hemodynamic parameters and GI symptoms in POTS. Two POTS cohorts were studied and compared with matched controls. In the fasting cohort, blood samples were drawn in 42 patients and 41 controls, followed by active standing tests with measurement of pulse and blood pressure (BP) in supine and standing positions. In the non-fasting cohort, questionnaires assessed GI symptoms and HbA1c was measured in 43 patients and 52 controls. Fasting C-peptide and insulin levels correlated with BP in POTS (q\u2009=\u20090.002) but not in controls. Fasting insulin tended to be higher in POTS but was not statistically significant after adjustment for BMI (\u03b2\u2009=\u20096.85; 95% CI: \u22121.04\u201314.74;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.085). Morning cortisol was comparable between groups. In the non-fasting cohort, HbA1c and metabolic hormones were comparable between groups, with no associations with GI symptoms. Together, these findings suggest a potential link between insulin-related pathways and BP regulation in POTS. Future studies are warranted to further investigate insulin dynamics in POTS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-52963-0","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:13Z","timestamp":1779200593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut hormones in POTS and their relation to hemodynamic parameters and gastrointestinal symptoms"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8789-8903","authenticated-orcid":false,"given":"Hanna","family":"Tufvesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-652X","authenticated-orcid":false,"given":"Bodil","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-9148","authenticated-orcid":false,"given":"Madeleine","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-0866","authenticated-orcid":false,"given":"Viktor","family":"Hamrefors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5352-6327","authenticated-orcid":false,"given":"Artur","family":"Fedorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8869-681X","authenticated-orcid":false,"given":"Eero","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-5244","authenticated-orcid":false,"given":"Bodil","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"52963_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/joim.12852","volume":"285","author":"A Fedorowski","year":"2019","unstructured":"Fedorowski, A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J. Intern. Med. 285, 352\u2013366 (2019).","journal-title":"J. Intern. Med."},{"key":"52963_CR2","doi-asserted-by":"publisher","first-page":"102828","DOI":"10.1016\/j.autneu.102828","volume":"235","author":"S Vernino","year":"2021","unstructured":"Vernino, S. et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 national institutes of health expert consensus meeting - part 1. Auton. Neurosci. 235, 102828. https:\/\/doi.org\/10.1016\/j.autneu.102828 (2021).","journal-title":"Auton. Neurosci."},{"key":"52963_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1212\/WNL.60.1.108","volume":"60","author":"CJ Sumner","year":"2003","unstructured":"Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R. & Polydefkis, M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60, 108\u2013111 (2003).","journal-title":"Neurology"},{"key":"52963_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/HYPERTENSIONAHA.121.17852","volume":"79","author":"NC Breier","year":"2022","unstructured":"Breier, N. C. et al. Worsening postural tachycardia syndrome is associated with increased glucose-dependent insulinotropic polypeptide secretion. Hypertension 79, 89\u201399 (2022).","journal-title":"Hypertension"},{"key":"52963_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-med-041818-011630","volume":"71","author":"PL Mar","year":"2020","unstructured":"Mar, P. L. & Raj, S. R. Postural orthostatic tachycardia syndrome: mechanisms and new therapies. Annu. Rev. Med. 71, 235\u2013248 (2020).","journal-title":"Annu. Rev. Med."},{"key":"52963_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3343\/alm.2013.33.6.393","volume":"33","author":"C Weykamp","year":"2013","unstructured":"Weykamp, C. HbA1c: a review of analytical and clinical aspects. Ann. Lab. Med. 33, 393\u2013400 (2013).","journal-title":"Ann. Lab. Med."},{"key":"52963_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10286-018-0519-x","volume":"28","author":"SE Mehr","year":"2018","unstructured":"Mehr, S. E., Barbul, A. & Shibao, C. A. Gastrointestinal symptoms in postural tachycardia syndrome: a systematic review. Clin. Auton. Res. 28, 411\u2013421 (2018).","journal-title":"Clin. Auton. Res."},{"key":"52963_CR8","doi-asserted-by":"publisher","unstructured":"Tufvesson, H., Hamrefors, V., Fedorowski, A., Hansson, M. & Ohlsson, B. Gastrointestinal symptoms in patients with postural orthostatic tachycardia syndrome in relation to hemodynamic findings and immunological factors. Front. Physiol. 15 (1342351). https:\/\/doi.org\/10.3389\/fphys.1342351 (2024).","DOI":"10.3389\/fphys.1342351"},{"key":"52963_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nmo.12480","volume":"27","author":"A Loavenbruck","year":"2015","unstructured":"Loavenbruck, A. et al. Disturbances of gastrointestinal transit and autonomic functions in postural orthostatic tachycardia syndrome. Neurogastroenterol Motil. 27, 92\u201398 (2015).","journal-title":"Neurogastroenterol Motil."},{"key":"52963_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MPG.0000000000001150","volume":"63","author":"JP Moak","year":"2016","unstructured":"Moak, J. P. et al. Antroduodenal manometry is abnormal in children presenting with orthostatic intolerance and gastrointestinal symptoms. J. Pediatr. Gastroenterol. Nutr. 63, 329\u2013335 (2016).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"52963_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI30076","volume":"117","author":"DJ Drucker","year":"2007","unstructured":"Drucker, D. J. The role of gut hormones in glucose homeostasis. J. Clin. Invest. 117, 24\u201332 (2007).","journal-title":"J. Clin. Invest."},{"key":"52963_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/ijmm.2012.1222","volume":"31","author":"M El-Salhy","year":"2013","unstructured":"El-Salhy, M., Mazzawi, T., Gundersen, D., Hatlebakk, J. G. & Hausken, T. The role of peptide YY in gastrointestinal diseases and disorders (review). Int. J. Mol. Med. 31, 275\u2013282 (2013).","journal-title":"Int. J. Mol. Med."},{"key":"52963_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.clinre.2016.12.007","volume":"41","author":"ZY Li","year":"2017","unstructured":"Li, Z. Y. et al. Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome. Clin. Res. Hepatol. Gastroenterol. 41, 459\u2013465 (2017).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"52963_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/joim.12895","volume":"286","author":"BH Shaw","year":"2019","unstructured":"Shaw, B. H. et al. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J. Intern. Med. 286, 438\u2013448 (2019).","journal-title":"J. Intern. Med."},{"key":"52963_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MAJ.0b013e31819f7587","volume":"338","author":"E Gulcan","year":"2009","unstructured":"Gulcan, E., Taser, F., Toker, A., Korkmaz, U. & Alcelik, A. Increased frequency of prediabetes in patients with irritable bowel syndrome. Am. J. Med. Sci. 338, 116\u2013119 (2009).","journal-title":"Am. J. Med. Sci."},{"key":"52963_CR16","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.3748\/wjg.14.4889","volume":"14","author":"EM Eriksson","year":"2008","unstructured":"Eriksson, E. M., Andr\u00e9n, K. I., Eriksson, H. T. & Kurlberg, G. K. Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. World J. Gastroenterol. 14, 4889\u20134896 (2008).","journal-title":"World J. Gastroenterol."},{"key":"52963_CR17","first-page":"2783","volume":"4","author":"M El-Salhy","year":"2012","unstructured":"El-Salhy, M. et al. Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front. Biosci. (Elite Ed). 4, 2783\u20132800 (2012).","journal-title":"Front. Biosci. (Elite Ed)"},{"key":"52963_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nutres.2020.12.001","volume":"86","author":"K Saidi","year":"2021","unstructured":"Saidi, K., Nilholm, C., Roth, B. & Ohlsson, B. A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction. Nutr. Res. 86, 23\u201336 (2021).","journal-title":"Nutr. Res."},{"key":"52963_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI30227","volume":"117","author":"DE Cummings","year":"2007","unstructured":"Cummings, D. E. & Overduin, J. Gastrointestinal regulation of food intake. J. Clin. Invest. 117, 13\u201323 (2007).","journal-title":"J. Clin. Invest."},{"key":"52963_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3892\/ijmm.2014.1811","volume":"34","author":"M El-Salhy","year":"2014","unstructured":"El-Salhy, M., Gilja, O. H., Gundersen, D., Hatlebakk, J. G. & Hausken, T. Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int. J. Mol. Med. 34, 363\u2013371 (2014).","journal-title":"Int. J. Mol. Med."},{"key":"52963_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/joim.12043","volume":"273","author":"A Fedorowski","year":"2013","unstructured":"Fedorowski, A., Burri, P., Struck, J., Juul-M\u00f6ller, S. & Melander, O. Novel cardiovascular biomarkers in unexplained syncopal attacks: the SYSTEMA cohort. J. Intern. Med. 273, 359\u2013367 (2013).","journal-title":"J. Intern. Med."},{"key":"52963_CR22","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","volume":"12","author":"RS Sheldon","year":"2015","unstructured":"Sheldon, R. S. et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 12, e41\u201363 (2015).","journal-title":"Heart Rhythm"},{"key":"52963_CR23","doi-asserted-by":"publisher","first-page":"8575","DOI":"10.1038\/s41598-021-87983-5","volume":"11","author":"M Johansson","year":"2021","unstructured":"Johansson, M. et al. Circulating levels of growth hormone in postural orthostatic tachycardia syndrome. Sci. Rep. 11, 8575. https:\/\/doi.org\/10.1038\/s41598-021-87983-5 (2021).","journal-title":"Sci. Rep."},{"key":"52963_CR24","doi-asserted-by":"publisher","unstructured":"Spahic, J. M. et al. Evidence for impaired renin activity in postural orthostatic tachycardia syndrome. J. Clin. Med. 12 (4660). https:\/\/doi.org\/10.3390\/jcm12144660 (2023).","DOI":"10.3390\/jcm12144660"},{"key":"52963_CR25","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","volume":"39","author":"M Brignole","year":"2018","unstructured":"Brignole, M. et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur. Heart J. 39, 1883\u20131948 (2018).","journal-title":"Eur. Heart J."},{"key":"52963_CR26","doi-asserted-by":"publisher","unstructured":"Bengtsson, M., Ohlsson, B. & Ulander, K. Development and psychometric testing of the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 7 https:\/\/doi.org\/10.1186\/1471-230X-7-16 (2007).","DOI":"10.1186\/1471-230X-7-16"},{"key":"52963_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis, C. Y., Morris, J. & Whorwell, P. J. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther. 11, 395\u2013402 (1997).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"52963_CR28","unstructured":"B-HbA1c (IFCC) Lab Medicine, Region Sk\u00e5ne, Analysportalen. [cited 2025 Sept 08]. (2025). Available from: http:\/\/analysportalen\/labmedicin.skane.se\/pics\/Labmedicin\/Verksamhetsomr%C3%A5den\/Klinisk%20kemi\/Analyser\/Skane\/B-HbA1c%20(IFCC).pdf"},{"key":"52963_CR29","unstructured":"B-Hemoglobin, B-E., Erc-MCH, E. M. C. V., Erc-MCHC, B-E-V-F. & Sysmex (eds) XN-10 samt XN-20: Lab Medicine, Region Sk\u00e5ne, Analysportalen; [cited 2025 Sept 08]. (2025). Available from: http:\/\/analysportalen-labmedicin.skane.se\/pics\/Labmedicin\/Verksamhetsomr%E5den\/Klinisk%20kemi\/Analyser\/Skane\/B-Hemoglobin%20(Hb),%20B-Erytrocyter,%20Erc-MCV,%20Erc-MCH,%20Erc-MCHC,%20B-EVF,%20Available from: Sysmex%20XN-10%20samt.pdf"},{"key":"52963_CR30","unstructured":"Kortisol, P. & Sk\u00e5ne, R. Lab Medicine, Analysportalen; [cited 2025 Sept 08]. (2025). Available from: http:\/\/analysportalen-labmedicin.skane.se\/pics\/Labmedicin\/Verksamhetsomr%C3%A5den\/Klinisk%20kemi\/Analyser\/Skane\/P-Kortisol%20p%C3%A5%20Cobas%20Pro.pdf"},{"key":"52963_CR31","unstructured":"McDonald, J. H. Handbook of Biological Statisticsm 3rd edn (Sparky House Publishing, 2014)."},{"key":"52963_CR32","doi-asserted-by":"publisher","unstructured":"Yao, J. et al. Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression. Neurosci. Biobehav Rev. 175 https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106218 (2025).","DOI":"10.1016\/j.neubiorev.2025.106218"},{"key":"52963_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1179\/2050854914Y.0000000023","volume":"81","author":"ME Cort\u00e9s","year":"2014","unstructured":"Cort\u00e9s, M. E. & Alfaro, A. A. The effects of hormonal contraceptives on glycemic regulation. Linacre Q. 81, 209\u2013218 (2014).","journal-title":"Linacre Q."},{"key":"52963_CR34","doi-asserted-by":"publisher","unstructured":"Dryga\u0142a, S., Radzikowski, M. & Maciejczyk, M. \u03b2-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress. Front. Pharmacol. 15 https:\/\/doi.org\/10.3389\/fphar.2024.1489657 (2024).","DOI":"10.3389\/fphar.2024.1489657"},{"key":"52963_CR35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/bmj.298.6681.1152","volume":"298","author":"T Pollare","year":"1989","unstructured":"Pollare, T., Lithell, H., Selinus, I. & Berne, C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Bmj 298, 1152\u20131157 (1989).","journal-title":"Bmj"},{"key":"52963_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-2796.2001.00829.x","volume":"250","author":"PT Sawicki","year":"2001","unstructured":"Sawicki, P. T. & Siebenhofer, A. Betablocker treatment in diabetes mellitus. J. Intern. Med. 250, 11\u201317 (2001).","journal-title":"J. Intern. Med."},{"key":"52963_CR37","doi-asserted-by":"publisher","unstructured":"Schrank, Y. et al. Proposal for fasting insulin and HOMA-IR reference intervals based on an extensive Brazilian laboratory database. Arch. Endocrinol. Metab. 68 https:\/\/doi.org\/10.20945\/2359-4292-2023-0483 (2024).","DOI":"10.20945\/2359-4292-2023-0483"},{"key":"52963_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/HYPERTENSIONAHA.120.16238","volume":"77","author":"AH Chopoorian","year":"2021","unstructured":"Chopoorian, A. H. et al. Impaired endothelial function in patients with postural tachycardia syndrome. Hypertension 77, 1001\u20131009 (2021).","journal-title":"Hypertension"},{"key":"52963_CR39","doi-asserted-by":"publisher","unstructured":"Sun, W. X., Chen, T. Y., Song, M. M., Gao, Y. J. & Xu, S. Y. Energy metabolism disorders in migraine: triggers, pathways, and therapeutic repurposing. Front. Neurol. 16 (1561000). https:\/\/doi.org\/10.3389\/fneur.2025.1561000 (2025).","DOI":"10.3389\/fneur.2025.1561000"},{"key":"52963_CR40","doi-asserted-by":"publisher","unstructured":"Dean, Y. E. et al. The relationship between irritable bowel syndrome and metabolic syndrome: a systematic review and meta-analysis of 49,662 individuals. Endocrinol. Diabetes Metab. 8 (e70041). https:\/\/doi.org\/10.1002\/edm2.70041 (2025).","DOI":"10.1002\/edm2.70041"},{"key":"52963_CR41","doi-asserted-by":"crossref","unstructured":"Norton, L., Shannon, C., Gastaldelli, A. & DeFronzo, R. A. Insulin: the master regulator of glucose metabolism. Metabolism. 129, 155142;10.1016\/j.metabol.155142 (2022). (2022).","DOI":"10.1016\/j.metabol.2022.155142"},{"key":"52963_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40292-020-00408-8","volume":"27","author":"C Mancusi","year":"2020","unstructured":"Mancusi, C. et al. Insulin resistance the hinge between hypertension and type 2 diabetes. High. Blood Press. Cardiovasc. Prev. 27, 515\u2013526 (2020).","journal-title":"High. Blood Press. Cardiovasc. Prev."},{"key":"52963_CR43","first-page":"671","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva, A. A. et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can. J. Cardiol. 36, 671\u2013682 (2020).","journal-title":"Can. J. Cardiol."},{"key":"52963_CR44","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1172\/JCI118124","volume":"96","author":"AD Baron","year":"1995","unstructured":"Baron, A. D. et al. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J. Clin. Invest. 96, 786\u2013792 (1995).","journal-title":"J. Clin. Invest."},{"key":"52963_CR45","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1152\/ajpendo.90549.2008","volume":"295","author":"AA Lteif","year":"2008","unstructured":"Lteif, A. A. et al. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans. Am. J. Physiol. Endocrinol. Metab. 295, 1510\u20131517 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"52963_CR46","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2337\/db06-1406","volume":"56","author":"A Lteif","year":"2007","unstructured":"Lteif, A., Vaishnava, P., Baron, A. D. & Mather, K. J. Endothelin limits insulin action in obese\/insulin-resistant humans. Diabetes 56, 728\u2013734 (2007).","journal-title":"Diabetes"},{"key":"52963_CR47","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1172\/JCI117433","volume":"94","author":"HO Steinberg","year":"1994","unstructured":"Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. & Baron, A. D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94, 1172\u20131179 (1994).","journal-title":"J. Clin. Invest."},{"key":"52963_CR48","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI115260","volume":"87","author":"EA Anderson","year":"1991","unstructured":"Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A. & Mark, A. L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87, 2246\u20132252 (1991).","journal-title":"J. Clin. Invest."},{"key":"52963_CR49","doi-asserted-by":"publisher","unstructured":"Al-Suhaimi, E. A. & Shehzad, A. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur. J. Med. Res. 18 (12). https:\/\/doi.org\/10.1186\/2047-783X-18-12 (2013).","DOI":"10.1186\/2047-783X-18-12"},{"key":"52963_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.metabol.2009.12.028","volume":"60","author":"J Jensen","year":"2011","unstructured":"Jensen, J., Ruge, T., Lai, Y. C., Svensson, M. K. & Eriksson, J. W. Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle. Metabolism 60, 215\u2013226 (2011).","journal-title":"Metabolism"},{"key":"52963_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1210\/jcem-54-1-131","volume":"54","author":"RA Rizza","year":"1982","unstructured":"Rizza, R. A., Mandarino, L. J. & Gerich, J. E. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J. Clin. Endocrinol. Metab. 54, 131\u2013138 (1982).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52963_CR52","doi-asserted-by":"publisher","unstructured":"Coupal, K. E. et al. Pubertal hormonal changes and the autonomic nervous system: potential role in pediatric orthostatic intolerance. Front. Neurosci. 13 (1197). https:\/\/doi.org\/10.3389\/fnins.2019.01197 (2019).","DOI":"10.3389\/fnins.2019.01197"},{"key":"52963_CR53","doi-asserted-by":"publisher","first-page":"103105","DOI":"10.1016\/j.autneu.2023.103105","volume":"248","author":"JKH Laurin","year":"2023","unstructured":"Laurin, J. K. H. et al. Adrenal gland response to adrenocorticotropic hormone is intact in patients with postural orthostatic tachycardia syndrome. Auton. Neurosci. 248, 103105. https:\/\/doi.org\/10.1016\/j.autneu.2023.103105 (2023).","journal-title":"Auton. Neurosci."},{"key":"52963_CR54","first-page":"185","volume":"38","author":"HF Khan","year":"2022","unstructured":"Khan, H. F., Ambreen, S., Raziq, H. & Hayat, A. Comparison of cortisol levels in patients with vasovagal syncope and postural tachycardia syndrome. Pak J. Med. Sci. 38, 185\u2013189 (2022).","journal-title":"Pak J. Med. Sci."},{"key":"52963_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jpeds.2017.08.039","volume":"191","author":"J Lin","year":"2017","unstructured":"Lin, J., Zhao, H., Shen, J. & Jiao, F. Salivary cortisol levels predict therapeutic response to a sleep-promoting method in children with postural tachycardia syndrome. J. Pediatr. 191, 91\u201395 (2017).","journal-title":"J. Pediatr."},{"key":"52963_CR56","doi-asserted-by":"crossref","unstructured":"Tufvesson, H., Hamrefors, V., Roth, B., Fedorowski, A. & Ohlsson, B. Sociodemographic factors, nutritional status, and inflammatory markers in patients with postural orthostatic tachycardia syndrome. Acta Neurol Scand. 1, 3992718;10.1155\/\/3992718 (2023). (2023).","DOI":"10.1155\/2023\/3992718"},{"key":"52963_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.regpep.2007.10.008","volume":"149","author":"LJ Karhunen","year":"2008","unstructured":"Karhunen, L. J., Juvonen, K. R., Huotari, A., Purhonen, A. K. & Herzig, K. H. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul. Pept. 149, 70\u201378 (2008).","journal-title":"Regul. Pept."},{"key":"52963_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jdiacomp.2014.12.006","volume":"29","author":"RE Kuhre","year":"2015","unstructured":"Kuhre, R. E., Wewer Albrechtsen, N. J., Hartmann, B., Deacon, C. F. & Holst, J. J. Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide. J. Diabetes Complications. 29, 445\u2013450 (2015).","journal-title":"J. Diabetes Complications"},{"key":"52963_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.peptides.2015.02.008","volume":"67","author":"M El-Salhy","year":"2015","unstructured":"El-Salhy, M., Hatlebakk, J. G., Gilja, O. H. & Hausken, T. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome. Peptides 67, 12\u201319 (2015).","journal-title":"Peptides"},{"key":"52963_CR60","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/nu11081824","volume":"11","author":"M El-Salhy","year":"2019","unstructured":"El-Salhy, M., Hatlebakk, J. G. & Hausken, T. Diet in irritable bowel syndrome (IBS): interaction with gut microbiota and gut hormones. Nutrients 11, 1824. https:\/\/doi.org\/10.3390\/nu11081824 (2019).","journal-title":"Nutrients"},{"key":"52963_CR61","doi-asserted-by":"publisher","unstructured":"Khan, U. et al. Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients. Front. Nutr. 12 (1615671). https:\/\/doi.org\/10.3389\/fnut.2025.1615671 (2025).","DOI":"10.3389\/fnut.2025.1615671"},{"key":"52963_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000442721","volume":"8","author":"V Yumuk","year":"2015","unstructured":"Yumuk, V. et al. European guidelines for obesity management in adults. Obes. Facts. 8, 402\u2013424 (2015).","journal-title":"Obes. Facts"},{"key":"52963_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.physbeh.2011.02.039","volume":"105","author":"RE Steinert","year":"2011","unstructured":"Steinert, R. E. & Beglinger, C. Nutrient sensing in the gut: interactions between chemosensory cells, visceral afferents and the secretion of satiation peptides. Physiol. Behav. 105, 62\u201370 (2011).","journal-title":"Physiol. Behav."},{"key":"52963_CR64","first-page":"903","volume":"273","author":"C Meyer","year":"1997","unstructured":"Meyer, C., Robson, D., Rackovsky, N., Nadkarni, V. & Gerich, J. Role of the kidney in human leptin metabolism. Am. J. Physiol. 273, 903\u2013907 (1997).","journal-title":"Am. J. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52963-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:02:51Z","timestamp":1779206571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52963-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52963"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52963-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15514"}}